Vivo Bio Tech Limited (BOM:511509)
India
· Delayed Price · Currency is INR 38.04
-0.02 (-0.05%)
At close: Jun 13, 2025
Vivo Bio Tech Revenue
In the fiscal year ending March 31, 2025, Vivo Bio Tech had annual revenue of 466.73M INR with 2.69% growth. Vivo Bio Tech had revenue of 122.91M in the quarter ending March 31, 2025, with 4.53% growth.
Revenue
466.73M
Revenue Growth
+2.69%
P/S Ratio
1.50
Revenue / Employee
2.90M
Employees
161
Market Cap
699.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 466.73M | 12.21M | 2.69% |
| Mar 31, 2024 | 454.51M | -67.79M | -12.98% |
| Mar 31, 2023 | 522.30M | 8.39M | 1.63% |
| Mar 31, 2022 | 513.91M | -3.84M | -0.74% |
| Mar 31, 2021 | 517.75M | -35.77M | -6.46% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |